QUADRANT CAPITAL GROUP LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$11,017
-59.0%
410
-45.6%
0.00%
-66.7%
Q2 2023$26,852
+24.1%
753
-11.6%
0.00%
+50.0%
Q1 2023$21,641
-45.7%
852
-13.2%
0.00%
-60.0%
Q4 2022$39,830
+148.9%
982
+105.9%
0.01%
+150.0%
Q3 2022$16,000
+128.6%
477
+136.1%
0.00%
+100.0%
Q2 2022$7,000
-30.0%
202
-5.6%
0.00%0.0%
Q1 2022$10,000
-66.7%
214
-52.4%
0.00%
-75.0%
Q4 2021$30,000
+57.9%
450
+46.6%
0.00%
+33.3%
Q3 2021$19,000
-24.0%
307
+3.0%
0.00%
-25.0%
Q2 2021$25,000
-7.4%
298
-27.7%
0.00%0.0%
Q1 2021$27,000
-12.9%
412
+2.0%
0.00%
-33.3%
Q4 2020$31,000
+181.8%
404
+59.1%
0.01%
+200.0%
Q3 2020$11,000
+10.0%
254
+10.4%
0.00%0.0%
Q2 2020$10,000
+900.0%
230
+434.9%
0.00%
Q1 2020$1,000
-95.2%
43
-88.5%
0.00%
-100.0%
Q4 2019$21,000
+950.0%
374
+249.5%
0.00%
Q3 2019$2,000
+100.0%
107
+91.1%
0.00%
Q2 2019$1,000560.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders